Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2





Top > Articles > Business of Medicine  

Web Links
Sort By :
71. Schering, Merck Shares Fall on Congressional Probe




Shares of Schering-Plough Corp and Merck & Co were down on Wednesday after U.S. lawmakers said they would look into allegations that the drugmakers were withholding data from a study of their shared cholesterol medicine Vytorin. Reuters Health Information
Category:   Articles > Business of Medicine

Date Added: Dec 17, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

72. FDA Device Clearances: Bone Marrow Biopsy System, Ceramic Spinal Implant, Mobile Bearing Knee Implan




The FDA has granted 510(k) clearance for a bone marrow biopsy system (OnControl) and special 510(k) clearance for a ceramic spinal implant (Valeo VBR), and it has approved a premarket application for a mobile bearing knee implant (NexGen LPS-Flex Mobile Knee). Medscape Medical News
Category:   Articles > Business of Medicine

Date Added: Dec 19, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

73. UK Psychiatrist Battles Demons Within and Without




A junior psychiatrist in the United Kingdom uses her blog to vent about the healthcare bureaucracy and about her own struggles with mental illness.
Medscape Med Students
Category:   Articles > Business of Medicine

Date Added: Dec 19, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

74. Manor Care Gets Pennsylvania Ok for Sale to Carlyle




Manor Care Inc has received key regulatory approval from the Pennsylvania Department of Health for its proposed $6.3 billion sale to private equity firm Carlyle Group [CYL.UL], the nursing home operator said on Monday. Reuters Health Information
Category:   Articles > Business of Medicine

Date Added: Dec 19, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

75. Galvus Gets Positive EU Opinion




Galvus (vildagliptin; Novartis), a dipeptidyl peptidase-IV (DPP-IV) inhibitor that improves cell responsiveness to glucose, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety concerns. Reuters Health Information
Category:   Articles > Business of Medicine

Date Added: Dec 19, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

76. Genzyme Thyroid Cancer Drug Gets Broader U.S. Use




Genzyme Corp on Monday said the U.S. Food and Drug Administration approved a broader use of thyroid cancer treatment Thyrogen. The new indication will extend use of the drug to patients earlier in their treatment, the Cambridge, Massachusetts-based biotech said. Reuters Health Information
Category:   Articles > Business of Medicine

Date Added: Dec 19, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

77. Japanese Hepatitis Patients Reject Government Aid Plan




Japanese patients infected with hepatitis C in a high-profile scandal over tainted blood, on Thursday rejected a government compensation proposal. Reuters Health Information
Category:   Articles > Business of Medicine

Date Added: Dec 21, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

78. FDA Approvals: Cymbalta, Sprycel, Seroquel XR




The FDA has approved an expanded indication for duloxetine HCl delayed-release capsules, a new dosage regimen for dasatinib, and an expanded indication for quetiapine fumarate extended-release tablets Medscape Medical News
Category:   Articles > Business of Medicine

Date Added: Dec 21, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

79. China Warns Against Complacency About Tuberculosis




China is not doing enough to fight tuberculosis and should not rest on its laurels with successes achieved to date, the health minister warned in an official newspaper on Wednesday. Reuters Health Information
Category:   Articles > Business of Medicine

Date Added: Dec 21, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

80. Genzyme Osteoarthritis Drug Gets European Approval




Genzyme Corp said it got European approval to market Synvisc-One for pain relief from osteoarthritis of the knee. Reuters Health Information
Category:   Articles > Business of Medicine

Date Added: Dec 21, 2007 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

Pages: [<< First] [< Previous] 3 4 5 6 7 8 9 10 11 12 [Next >] [Last >>]

Category Jump :



Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS